Altamira Therapeutics Statistics
Total Valuation
CYTOF has a market cap or net worth of 405,799. The enterprise value is -231,772.
| Market Cap | 405,799 |
| Enterprise Value | -231,772 |
Important Dates
The last earnings date was Thursday, April 17, 2025.
| Earnings Date | Apr 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CYTOF has 5.72 million shares outstanding. The number of shares has increased by 476.54% in one year.
| Current Share Class | 5.72M |
| Shares Outstanding | 5.72M |
| Shares Change (YoY) | +476.54% |
| Shares Change (QoQ) | +74.89% |
| Owned by Insiders (%) | 18.81% |
| Owned by Institutions (%) | 0.00% |
| Float | 4.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.06 |
| P/TBV Ratio | 0.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.03 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.04 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.32 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.06 |
| Interest Coverage | -345.95 |
Financial Efficiency
Return on equity (ROE) is -118.79% and return on invested capital (ROIC) is -58.18%.
| Return on Equity (ROE) | -118.79% |
| Return on Assets (ROA) | -48.12% |
| Return on Invested Capital (ROIC) | -58.18% |
| Return on Capital Employed (ROCE) | -91.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -768,886 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.76 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 45.22 |
| Average Volume (20 Days) | 6,238 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.11 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.85M |
| Pretax Income | -8.46M |
| Net Income | -8.46M |
| EBITDA | n/a |
| EBIT | -6.85M |
| Earnings Per Share (EPS) | -2.99 |
Balance Sheet
The company has 998,624 in cash and 361,053 in debt, giving a net cash position of 637,571 or 0.11 per share.
| Cash & Cash Equivalents | 998,624 |
| Total Debt | 361,053 |
| Net Cash | 637,571 |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 6.57M |
| Book Value Per Share | 1.41 |
| Working Capital | 376,215 |
Cash Flow
In the last 12 months, operating cash flow was -6.11 million and capital expenditures -103,087, giving a free cash flow of -6.22 million.
| Operating Cash Flow | -6.11M |
| Capital Expenditures | -103,087 |
| Free Cash Flow | -6.22M |
| FCF Per Share | -1.09 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CYTOF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -476.54% |
| Shareholder Yield | -476.54% |
| Earnings Yield | -2,084.22% |
| FCF Yield | -1,531.95% |
Stock Splits
The last stock split was on December 13, 2023. It was a reverse split with a ratio of 0.05.
| Last Split Date | Dec 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |